PESARINI, Gabriele
 Distribuzione geografica
Continente #
EU - Europa 5.086
NA - Nord America 4.408
AS - Asia 3.675
SA - Sud America 456
AF - Africa 148
OC - Oceania 13
Totale 13.786
Nazione #
US - Stati Uniti d'America 4.295
RU - Federazione Russa 2.325
SG - Singapore 1.513
CN - Cina 1.020
GB - Regno Unito 884
IT - Italia 505
BR - Brasile 360
HK - Hong Kong 336
VN - Vietnam 318
FR - Francia 257
DE - Germania 251
SE - Svezia 229
IE - Irlanda 192
FI - Finlandia 187
KR - Corea 132
IN - India 65
CA - Canada 59
NL - Olanda 42
UA - Ucraina 42
ID - Indonesia 39
AR - Argentina 35
MX - Messico 35
ZA - Sudafrica 34
TR - Turchia 33
JP - Giappone 31
PL - Polonia 30
TG - Togo 30
NG - Nigeria 29
ES - Italia 28
IQ - Iraq 28
BD - Bangladesh 26
BE - Belgio 21
BJ - Benin 21
UZ - Uzbekistan 18
CO - Colombia 15
EC - Ecuador 15
PK - Pakistan 15
MA - Marocco 14
LT - Lituania 13
VE - Venezuela 13
AT - Austria 11
CZ - Repubblica Ceca 11
IR - Iran 11
AZ - Azerbaigian 10
IL - Israele 9
KG - Kirghizistan 9
AU - Australia 8
CH - Svizzera 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
AL - Albania 6
CL - Cile 6
OM - Oman 6
RO - Romania 6
TN - Tunisia 6
HU - Ungheria 5
JM - Giamaica 5
NP - Nepal 5
DK - Danimarca 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
PE - Perù 4
PS - Palestinian Territory 4
PT - Portogallo 4
SA - Arabia Saudita 4
SI - Slovenia 4
TH - Thailandia 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
HR - Croazia 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
BH - Bahrain 2
BZ - Belize 2
EE - Estonia 2
EG - Egitto 2
GT - Guatemala 2
KH - Cambogia 2
LB - Libano 2
MT - Malta 2
MY - Malesia 2
PA - Panama 2
TJ - Tagikistan 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CR - Costa Rica 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KI - Kiribati 1
Totale 13.773
Città #
Moscow 824
Singapore 798
Southend 742
Ashburn 663
San Jose 534
Dallas 395
Chandler 368
Hong Kong 333
Jacksonville 224
Beijing 209
Verona 197
Dublin 190
New York 173
The Dalles 157
Los Angeles 118
Ho Chi Minh City 102
Helsinki 97
Munich 97
Woodbridge 96
Hanoi 85
Ann Arbor 82
Houston 71
Jinan 66
Lawrence 58
Princeton 58
Wilmington 52
Shenyang 49
São Paulo 49
Santa Clara 43
London 39
Tianjin 39
Buffalo 38
Milan 38
Nanjing 37
Redondo Beach 37
Orem 35
Hebei 34
Turku 32
Lomé 30
Seattle 30
Montreal 29
Seoul 29
Frankfurt am Main 27
Tokyo 27
Columbus 26
Sindelfingen 26
Warsaw 25
Abuja 24
Chennai 24
Denver 24
Johannesburg 24
Amsterdam 23
Nanchang 23
Taizhou 23
Zhengzhou 23
Changsha 22
Rome 22
Cedar Knolls 21
Cotonou 21
Guangzhou 21
Brussels 20
Council Bluffs 20
Haikou 20
Stockholm 20
Brooklyn 19
Taiyuan 18
Washington 18
Atlanta 17
Da Nang 17
Ningbo 17
Phoenix 17
Toronto 17
Falkenstein 16
Kent 16
Poplar 16
Haiphong 15
Hangzhou 15
Jakarta 15
Tashkent 15
Baghdad 14
Nuremberg 14
Paris 14
San Francisco 14
Boston 13
Lappeenranta 13
Redwood City 13
Jiaxing 12
Rio de Janeiro 12
Belo Horizonte 11
Fairfield 11
Mexico City 11
Norwalk 11
Shanghai 11
Biên Hòa 10
Brasília 10
Chicago 10
Fuzhou 10
Lanzhou 10
Madrid 10
Baku 9
Totale 8.374
Nome #
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency 586
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation 211
MODULAZIONE DELLA RISPOSTA INFIAMMATORIA NELLA PREVENZIONE DELLA RESTENOSI POST STENT CORONARICO: IL TRIAL CLINICO MULTICENTRICO RANDOMIZZATO “CEREA-DES” 208
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 204
Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions 202
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 191
"Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option" 190
Hemodynamic predictors of long term survival in end stage cystic fibrosis 186
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 185
"Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy" 185
Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population 183
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 181
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. 177
Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI 176
Comparative Prognostic Value of Parameters of Pulsatile Right Ventricular Afterload in Patients With Advanced Heart Failure Awaiting Heart Transplantation 175
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation Influence of Pressure Overload on the Evaluation of Lesions Severity 175
Physiologic Evaluation of Coronary Lesions Using Instantaneous Wave-free Ratio (iFR) in Patients with Severe Aortic Stenosis Undergoing Trans-catheter Aortic Valve Implantation 173
Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio 171
Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure 166
Transcatheter valve-in-mitral homograft in tricuspid position: first-in-man report 164
Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation 163
Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI 161
Coronary artery disease in patients undergoing transcatheter aortic valve implantation. A single centre registry on prevalence, management and immediate clinical impact 161
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 159
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 157
Intravascular ultrasound assessment of coronary ostia following valve in valve transcatheter aortic valve implantation 157
Contrast-Induced Nephropathy in Patients Undergoing Staged Versus Concomitant Transcatheter Aortic Valve Implantation and Coronary Procedures 156
Devices for mechanical circulatory support and strategies for their management in cardiogenic shock 156
Impella-protected PCI: the clinical results achieved so far 153
Acute electrocardiographic differences between Takotsubo cardiomyopathy and anterior ST elevation myocardial infarction 150
Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI 150
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS). 149
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 146
Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis 145
Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy 145
Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy 145
Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation 144
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. 144
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans. 143
Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves 143
Long-term variations of FFR and iFR after transcatheter aortic valve implantation 142
New-onset extreme right axis deviation in acute myocardial infarction: clinical characteristics and outcomes 142
Comparison of the long-term survival benefits associated with revascularization or medical therapy in patients with known coronary artery disease undergoing transesophageal atrial pacing stress echocardiography 139
Angiography-derived index of microvascular resistance in takotsubo syndrome 139
Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI 138
Transapical mitral valve-in-valve procedure with elective venoarterial ECMO in a patient with severe kyphoscoliosis 133
Risk stratification in acute coronary syndromes. 133
Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation 132
Bail-out transcatheter aortic valve implantation to reduce severe acute aortic regurgitation in a failing homograft secondary to HeartMate II ventricular assistance device 131
Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes 130
Extravalvular Cardiac Damage and Renal Function Following Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis 130
First Observation of a "Golden Tube" After Complete Resorption of a Bioresorbable Vascular Scaffold in a Transplanted Patient With Cardiac Allograft Vasculopathy 127
Functional Patterns of Coronary Disease: Diffuse, Focal, and Serial Lesions 126
Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses. 125
Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES) 124
Recurrent very late drug-eluting stent thrombosis. 122
Cardiovascular imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy 120
Choosing transcatheter aortic valve replacement in porcelain aorta: outcomes versus surgical replacement 120
Long-term intracoronary imaging and physiological measurements of bioresorbable scaffolds and untreated atherosclerotic plaques 119
Early shifts in serum creatinine concentrations can predict contrast-induced nephropathy and persistent renal damage following angiography,Modificazioni precoci nella concentrazione della creatininemia sono in grado di predire la nefropatia da mezzo di contrasto e il danno renale persistente dopo angiografia 119
Clinical Updates in Coronary Artery Disease: A Comprehensive Review 116
Dynamic changes of repolarization abnormalities in takotsubo cardiomyopathy 116
Repeat revascularization: Percutaneous coronary intervention after coronary artery bypass graft surgery 114
Vascular complications after transcatheter aortic valve implantation: treatment modalities and long-term clinical impact 113
Long-Term Outcomes of Coronary and Carotid Artery Disease Revascularization in the FRIENDS Study 111
Percutaneous Impella Recover circulatory support in high-risk coronary angioplasty. 110
Transapical Transcatheter Aortic Valve Replacement: A Real-World Early and Mid-Term Outcome of a Third-Level Centre 106
Intraventricular entrapment of a Sapien-3 balloon in transapical TAVR: A near missed catastrophe 106
Functional Patterns of Coronary Disease: Diffuse, Focal, and Serial Lesions 105
Osteomyelitis of the clavicle following to a pacemaker implantation 105
Radial artery occlusion after conventional and distal radial access: Impact of preserved flow and time-to-hemostasis in a propensity-score matching analysis of 1163 patients 104
Quality of Life after Transcatheter Aortic Valve Replacement in Sarcopenic Patients Using the Toronto Aortic Stenosis Quality of Life Questionnaire 104
Coronary obstruction after transcatheter aortic valve replacement combined with basilica procedure 102
Radial artery occlusion after transradial procedures: impact on 1-year adverse events 102
Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction 102
Right Ventricle Pulmonary Artery Coupling and Renal Function in Patients With Severe Aortic Stenosis Undergoing TAVR 101
Incomplete functional revascularization is associated with adverse clinical outcomes after transcatheter aortic valve implantation 100
Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI 99
Transcatheter tricuspid valve implantation by femoral approach in trivalvular heart disease 99
Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential. 99
Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience 98
Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry. 97
Early and late clinical outcomes of endovascular, surgical, and hybrid revascularization strategies of combined carotid and coronary artery diseases: the FRIENDS study group (Finalized Research In ENDovascular Strategies) 96
Predictors of patent and occlusive hemostasis after transradial coronary procedures 96
Integrated Assessment of Computational Coronary Physiology From a Single Angiographic View in Patients Undergoing TAVI 94
Predictors and Prognostic Impact of Left Ventricular Ejection Fraction Recovery after Impella-Supported Percutaneous Coronary Interventions in Acute Myocardial Infarction 93
Early Postoperative Thrombosis of Transcatheter Aortic Valve-in-Valve Prosthesis 92
Is transfemoral aortic valve implantation possible without contrast medium in patients with renal and multiorgan failure? 91
Letter by Ribichini et al regarding article, "Cystatin C and contrast-induced acute kidney injury". 91
Single-side renal sympathetic denervation to treat malignant refractory hypertension in a solitary kidney patient 91
Ten-year experience with a transapical approach for transcatheter aortic and mitral valve implantation 90
Current Antithrombotic Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Interventions 89
Ten-Year Experience with Endomyocardial Biopsy after Orthotopic Heart Transplantation: Comparison between Trans-Jugular and Trans-Femoral Approach 89
Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART) 87
Transfemoral Edwards-Novaflex valve implantation in a patient with aorto-iliac endoprosthesis and severely tortuous bilateral external iliac arteries-"Railing track" 85
Short-and-Long-Term Outcomes after Coronary Rotational Atherectomy in Patients Treated with Trans-Catheter Aortic Valve Implantation 82
Transcatheter edge-to-edge mitral valve repair: what is the measure of success? 81
Increased Thrombogenicity is Associated With Coronary Microvascular Dysfunction in Patients With STEMI-A Proof-of-Concept Study 77
Significant Drop in Right Atrial Pressure Does Not Influence Fractional Flow Reserve Coronary Assessment 77
The promise of vascular reparative therapy in standby mode. How long before a final decision? Complete vessel wall regeneration and vascular scaffold resorption after left anterior descending reconstructions 76
Totale 13.593
Categoria #
all - tutte 49.930
article - articoli 49.458
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 472
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.860


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 0 0 0 0 47 8
2021/2022431 47 117 5 41 7 5 2 19 16 11 53 108
2022/20231.221 68 179 103 156 92 289 49 68 150 13 36 18
2023/20241.013 22 58 77 125 99 227 48 84 10 69 157 37
2024/20252.325 104 117 103 395 163 113 75 106 369 178 190 412
2025/20266.904 466 278 432 1.318 1.951 487 675 375 576 339 7 0
Totale 13.901